Portfolio
As of August 31, 2020
NBPE Summary
| NBPE $ in millions, except per share | 8/31/2020 | 7/31/2020 (Re-Stated) |
| Equity Investments (Pro Forma) | $956.5 | $970.1 |
| Income Investments | 125.5 | 117.7 |
| Total Direct Investments | $1,082.0 | $1,087.8 |
| Legacy Private Equity Funds | 21.7 | 23.8 |
| Total Private Equity Fair Value (Pro Forma) | $1,103.7 | $1,111.6 |
| Cash (Pro Forma) | 7.2 | 10.0 |
| Credit Facility Borrowings | (105.0) | (110.0) |
| ZDPs | (151.7) | (148.2) |
| Dividend Payable | - | (13.6) |
| Other Assets / Liabilities (Net) | 6.3 | 5.2 |
| Net Asset Value | $860.4 | $855.0 |
| Net Asset Value Per Share | $18.40 | $18.28 |
| Capital Position | 8/31/2020 | 7/31/2020 (Re-Stated) |
| Investment Level | 128% | 130% |
| Cash + Available Credit Facility (Pro Forma) | 202.2 | 200.0 |
| Adjusted Unfunded Commitments | 109.8 | 118.8 |
| Adjusted Commitments Coverage Ratio (Pro Forma) | 184% | 168% |
| Sterling NAV & Trading Information (£) | 8/31/2020 | 7/31/2020 (Re-Stated) |
| NAV Per Share | £13.74 | £13.93 |
| Closing Share Price | £9.10 | £8.92 |
| Discount to NAV | (33.8%) | (36.0%) |
Asset Overview
TOP 10 POSITIONS BY FAIR VALUE
| Investment | Inv. Date | Industry | Fair Value ($m) | % of Value |
|---|---|---|---|---|
| ProAmpac | 2017 | Industrials | 36.9 | 3.3 |
|
|
||||
| MHS | 2017 | Industrials | 33.9 | 3.1 |
|
|
||||
| Agiliti | 2019 | Healthcare | 32.8 | 3.0 |
|
|
||||
| USI | 2017 | Financial Services | 32.0 | 2.9 |
|
|
||||
| Business Services Company (Undisclosed) | 2017 | Business Services | 30.9 | 2.8 |
|
|
||||
| Action | 2020 | Consumer | 28.7 | 2.6 |
|
|
||||
| Marquee Brands | 2014 | Consumer | 28.4 | 2.6 |
|
|
||||
| Cotiviti | 2018 | Healthcare | 28.0 | 2.5 |
|
|
||||
| Telxius | 2017 | Communications | 27.7 | 2.5 |
|
|
||||
| Beyond Trust | 2018 | TMT | 25.9 | 2.4 |
|
|
||||
| Total | 305.2 | 27.7 | ||
INVESTOR RELATIONS
NBPE’s Class A ordinary shares are admitted to trading on the Premium Segment of the Main Market of the London Stock Exchange
LEARN MORE